Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 DiabetesBirnbaum et al. Here, NLRP3 is linked to diabetic kidney disease.